SCI Abstract

search
Cumulative Duration of Severe Psoriasis: A Novel Cardiovascular Risk Predictor for Dermatologists
Cumulative Duration of Severe Psoriasis: A Novel Cardiovascular Risk Predictor for Dermatologists
The association between moderate-to-severe psoriasis and cardiovascular (CV) risk is well known. No clear link between dis...
Scalp Rosacea: Current Evidence
Scalp Rosacea: Current Evidence
Scalp rosacea, also known as red scalp disease (RSD), is an inflammatory dermatosis that remains underrecognized and frequ...
Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib
Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib
Patients with vitiligo reportedly have an increased risk of sensorineural hearing loss (SNHL), driven by the loss of extra...
Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review
Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review
Over the past two decades, numerous highly effective biological treatments have been developed for patients with moderate-...
Paving the Way to Healthcare Equity: A Comprehensive Review of Care Gaps and Emerging Initiatives in Dermatology
Paving the Way to Healthcare Equity: A Comprehensive Review of Care Gaps and Emerging Initiatives in Dermatology
Historically, dermatology research and clinical practice in the United States (USA) have overlooked important consideratio...
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year
Individuals with psoriatic arthritis (PsA) and plaque-type psoriasis and nail involvement have more severe disease and wor...
Exploring New Dimensions in Longitudinal Rosacea Management
Exploring New Dimensions in Longitudinal Rosacea Management
Rosacea is a common, chronic, inflammatory disease of the skin, which predominantly (but not exclusively) affects the cent...
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial
This Summary of Research provides an overview of the results of a phase 3 study that assessed the efficacy and sa...
Treatment Preferences Among Systemic Therapy-Naïve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study
Treatment Preferences Among Systemic Therapy-Naïve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study
Despite the expanding range of approved systemic therapies for atopic dermatitis (AD) and psoriasis (PSO), data on patient...
Advances in Pathophysiology and Therapeutic Paradigm Shifts in Chronic Spontaneous Urticaria: A Narrative Review
Advances in Pathophysiology and Therapeutic Paradigm Shifts in Chronic Spontaneous Urticaria: A Narrative Review
Chronic spontaneous urticaria (CSU) is a debilitating inflammatory skin disorder characterized by recurrent wheals and/or ...
Survey on the Actual Use of Topical Anti-Inflammatory Drugs Among Patients with Atopic Dermatitis
Survey on the Actual Use of Topical Anti-Inflammatory Drugs Among Patients with Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin condition requiring long-term management to maintain remission and p...
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense itching, redness, and eczema. It ...
Clinical Implications of the Skin Microbiota in the Therapy of Cutaneous T Cell Lymphoma: A Scoping Review
Clinical Implications of the Skin Microbiota in the Therapy of Cutaneous T Cell Lymphoma: A Scoping Review
Cutaneous T cell lymphomas (CTCL) are non-Hodgkin T cell malignancies defined by malignant T ce...